EML4-ALK and EGFR mutation status and survival analysis in Uygur with stage Ⅳ NSCLC

WANG Qiang1， ZHANG Qiao1， CAO Yanzhen2， TAO Jie1， SHAN Li1△

Tianjin Medical Journal . 2016, (2): 200 -204 . DOI: 10.11958/58911